PFG Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
PFG Advisors's XBI Position: Q3 2026 in Review
PFG Advisors opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q3 2026: 11,480 shares worth $1.81M. The stake represents 0.09% of the portfolio and ranks #257 among its holdings. This is a return to the name: PFG Advisors previously reported a position in XBI as recently as Q1 2025.
PFG Advisors first reported a position in XBI in Q3 2020 and has held it in 20 quarters since. The position peaked at $8.97M in Q3 2024. 963 funds tracked by Wall St. Rank hold XBI as of Q3 2026.
- PFG Advisors held 11,480 shares of State Street SPDR S&P Biotech ETF worth $1.81M as of Q3 2026.
- State Street SPDR S&P Biotech ETF was a new PFG Advisors position in Q3 2026.
- State Street SPDR S&P Biotech ETF made up 0.09% of PFG Advisors's portfolio in Q3 2026, its #257 holding.
- PFG Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q3 2020 and has held it in 20 quarters since.
- PFG Advisors's State Street SPDR S&P Biotech ETF position peaked at $8.97M in Q3 2024.
- 963 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.
Based on PFG Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.